Integrating EVs with nanotechnology shows great promise for early disease detection and therapeutic intervention. For example, engineered EVs can carry specific therapeutic materials directly to affected CNS regions, improving treatment effectiveness and reducing side effects. This approach is particularly promising for neurodegenerative diseases like AD and PD, where early diagnosis and targeted treatment are crucial for slowing disease progression and improving patient outcomes.
In their comprehensive review, Hye Kyu Choi, Meizi Chen, Li Ling Goldston, and Prof. Ki-Bum Lee highlight recent advancements in using nanotechnology-assisted EVs for CNS diagnostics and treatments. They discussed how EVs can overcome the limitations of current diagnostic and therapeutic strategies, offering a synergistic approach that combines the unique properties of EVs with the advanced capabilities of nanotechnology.
Continued research into integrating EVs and nanotechnology is essential to refine these advanced treatment platforms further. By enhancing targeting mechanisms, improving early disease detection methods, and minimizing invasiveness, researchers can develop more effective and patient-friendly interventions for CNS diseases. This interdisciplinary approach promises to bridge the gap between foundational research and clinical application, ultimately offering new hope and significant relief to individuals suffering from these debilitating conditions.
PUBLICATION: This work was recently published in Nano Convergence, 2024, https://doi.org/10.1186/s40580-024-00426-5
AUTHORS: Hye Kyu Choi, Meizi Chen, Li Ling Goldston and Ki-Bum Lee
CORRESPONDENCE: Prof. Ki-Bum Lee (Rutgers University), https://kblee.rutgers.edu/
KBLEE Group Team: Dr. Euiyeon Lee, Dr. Hye Kyu Choi, https://kblee.rutgers.edu/
